B-60. They were named sattabacin (1), hydroxysattabacin (2), sattazolin (3) and methylsattazolin (4) . The biologically active compoundswere recovered from fermentation broth by ethyl acetate extraction and silica-gel column fractionation. Their antiviral activity was mainly expressed against the Herpes simplex viruses type 1 and 2. The compound3 showed a selective inhibition of protein synthesis in Herpesvirus-infected cells.
Bacteria have been shown to be a commonsource of antibiotics and other biologically active substances1~4). In addition, it has been claimed that original antiviral drugs are produced by some species of the genus During a screening program for the detection of biologically active compounds from environmental microorganisms, we isolated and selected a Bacillus sp. which produced two types of novel compounds, namely sattabacins and sattazolins, endowed with specific antiviral properties.
Taxonomyof Producing Strain
A strain of aerobic, spore-forming bacillus was isolated from soil samples taken in Cagliari (Sardinia, Italy). It was identified as a species close to Bacillus lentus and B.
firmus, through its morphological, biochemical and physiological properties and also by using the API 50 CHB system (Bio-Merieux, Italia), but, it differed from the former in arbutin, gelatin and citrate tests, and from the latter in glycerol, arbutin and urease tests (Table 1) . After 18 hours at 28°C under shaking conditions (250rpm) in a dry incubator (New Brunswick model G25), the microbial suspension was seeded in agar plates of medium AR-2 with the addition of 1 1 g/liter of purified agar (Oxoid, Basingstoke, U.K.). These were incubated for 5 days at 28°C. Subsequently the plates underwent a cycle of freezing and thawing to extract the medium together with the products of fermentation. The extract was clarified by centrifuging at 8000 rpm for 15 minutes.
Isolation
Scheme1 summarises the steps followed to obtain the pure substances. The solution (30 liters) was extracted twice with 20% EtOAc (v/v). The solvent was collected and dried in a vacuumevaporator. The crude extract (1.3 g) was chromatographed on a silica gel column eluted with an increasing amount of EtOAc in C6H6 affording (Table 2) showed resonances for two methylenes, one saturated carboiiyl, two methyls and two methines (one of which oxygenated), for the C7H13O2 chain. Multiplicities of the XHNMRsignals and decoupling experiments revealed the presence of two separated partial structures for the chain, respectively, -CH2-CH(OH)-and -CH2-CH(Me)2. These data may be arranged as in structure 1. Accordingly, 1 exhibited ions at mjz 149 and mjz 121 in the mass spectrum, due to the losses of C4H9 and C5H9Ofragments, respectively, from the molecular ion.
Compound2, C13H18O3, was assigned the structure 2 because it showed the same NMRsignals for the chain of 1 and other signals attributable to a p-hydroxybenzene.
Sattazolin (3) and 2' -methylsattazolin (4) : Compound 3, C15H19NO2,again exhibited the same NMRdata as 1 for the chain (Table 2) . Notably, the 13C NMR signal attributed to the methylene in position 2' was shielded (lO ppm) indicating a different aromatic moiety to which the C7H13O2chain is' linked. With respect to the C8H6Naromatic part, it gave *H and 13C/APT Comparison of the 13C NMRdata (Table 2) The only major difference between the NMRspectra of compound 3 and 4, C16H11NO2,was the presence in the latter of a signal more commonly (dH 3.34 and dc 58.2) attributed to a methoxy group. The location of this substituent on C-2' was indicated by the deshielding (d SI.2 vs. d 76.9) of this signal in the 13C NMRspectrum (Table 2) .
Biological Properties The anti-viral activity of the new compounds, tested with a plaque reduction assay is indicated in Table 3 and is refered as ID50.
In the virus plaque reduction assay, the ID50 for 1 was 3jng/m\ on both HSV1 and HSV2, 1.5//g/ml for 3, 35/ig/ml for compound 4 on HSV1 and as low as 0. Compound3 was less active than 1 and 2 on viruses. The methylation in position 2' induced a great decrease of the toxic activity of compound 4, but also of its antiviral activity, especially on HSV2. The mechanism of action of these new compounds has VOL.48 NO. 9 THE JOURNAL OF ANTIBIOTICS not yet been clarified. One of the compounds (3) seems to affect protein synthesis at the highest doses used, with a selectivity between infected and non-infected cells.
Further work is needed to elucidate the structureactivity relationship, with the aim of modifying these new compoundsor of synthesizing other more selective derivatives.
Experimental
NMRspectra were obtained on a Varian Gemini-300 spectrometer in CDC13 (TMS as reference). Mass spectra were run on a AEI 12 instrument at 70eV.
Sattabacin (1)
Ci3H18O2.
[a]D=+35°(c 0.7, CHC13 
Antibiotic Activity Assay
Antibacterial and antifungal activity was studied by a dilution method in multiwell plates using Muller-Hinton broth (for bacteria)12) and Sabouraud broth (for fungi), according to standard conditions13).
